CG

Clinton Group Portfolio holdings

AUM $279M
1-Year Est. Return 4.7%
This Quarter Est. Return
1 Year Est. Return
+4.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$279M
AUM Growth
-$361M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
447
New
Increased
Reduced
Closed

Top Buys

1
+$10.4M
2
+$9.25M
3
+$8.58M
4
BAX icon
Baxter International
BAX
+$8.09M
5
NEE icon
NextEra Energy
NEE
+$6.02M

Top Sells

1
+$13.1M
2
+$11.7M
3
+$10.1M
4
ABBV icon
AbbVie
ABBV
+$7.66M
5
LMT icon
Lockheed Martin
LMT
+$7.27M

Sector Composition

1 Financials 24.59%
2 Consumer Discretionary 12.16%
3 Healthcare 11.33%
4 Technology 10.66%
5 Utilities 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAR
301
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-21,570
TIF
302
DELISTED
Tiffany & Co.
TIF
– –
-18,463
VER
303
DELISTED
VEREIT, Inc.
VER
– –
-39,251
AMTD
304
DELISTED
TD Ameritrade Holding Corp
AMTD
– –
-14,437
LOGM
305
DELISTED
LogMein, Inc.
LOGM
– –
-8,132
GNC
306
DELISTED
GNC Holdings, Inc.
GNC
– –
-29,829
CHK
307
DELISTED
Chesapeake Energy Corporation
CHK
– –
-62
PGNX
308
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-14,996
EQM
309
DELISTED
EQM Midstream Partners, LP
EQM
– –
-58,222
WBC
310
DELISTED
WABCO HOLDINGS INC.
WBC
– –
-26,506
MLNX
311
DELISTED
Mellanox Technologies, Ltd.
MLNX
– –
-38,169
TGE
312
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
– –
-32,340
AKS
313
DELISTED
AK Steel Holding Corp
AKS
– –
-32,215
LPT
314
DELISTED
Liberty Property Trust
LPT
– –
-16,931
WCG
315
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-13,356
AVP
316
DELISTED
Avon Products, Inc.
AVP
– –
-63,875
WP
317
DELISTED
Worldpay, Inc.
WP
– –
-32,085
DNB
318
DELISTED
Dun & Bradstreet
DNB
– –
-39,961
DELL icon
319
Dell
DELL
$89.6B
– –
-225,346
PNR icon
320
Pentair
PNR
$17.4B
– –
-70,899
EXPR
321
DELISTED
Express, Inc.
EXPR
– –
-643
A icon
322
Agilent Technologies
A
$42.2B
– –
-62,169
AAL icon
323
American Airlines Group
AAL
$9.61B
– –
-27,629
AAPL icon
324
Apple
AAPL
$4.2T
– –
-44,652
ABBV icon
325
AbbVie
ABBV
$407B
– –
-82,667
11 12
13
14 15